Exelixis Announces EMA Acceptance of Marketing Authorization...
Exelixis, Inc. today announced the European Medicines Agency has accepted for review the Marketing Authorization Application for COMETRIQ for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .
Join the discussion below, or Read more at Freshnews.
#1 Nov 30, 2012
Looking for more information on Cometriq? Here's a pharmacist's description: http://www.rxwiki.com/cometriq
#2 Dec 13, 2012
We don't have the time to keep up with the current marketing trends. We are looking for a marketing firm grand rapids who is forward thinking. Any recommendations?
Add your comments below
|Doritos makes rainbow chips in support of gay r... (Sep '15)||4 hr||guest||690|
|APNewsBreak: Feds advise workaround on asset fo...||14 hr||Cordwainer Trout||2|
|Gas prices soar in Lakeway Area (Feb '08)||Jan 16||Omg||46|
|Music icons Bryan Adams and Madness to play Ede...||Jan 15||Maddy||1|
|Hamilton-Halton United Way merger expected to b...||Jan 13||Pearl||2|
|IAC plant in Old Fort to lay off 60 workers (Oct '08)||Jan 11||Millie||12|
|Kraft's salad dressing fix: Shake up well (Feb '08)||Jan 10||Toby||54|
Find what you want!
Search Marketing Forum Now
Copyright © 2017 Topix LLC